Cancer
Vaccines helps to boost the immune system's recognition
and resistance to cancer cells. Thus, increased knowledge of our immune
system has opened up new combination therapies in immuno-oncology, to
enhance immune response, as some the latest treatments incorporate
monoclonal antibodies and genetically engineered viral vectors to kill
tumours.
Some of the hottest topics will include:
• CAR T-Cell Therapy
• Oncolytic viral therapies
• Gene-therapy
• Adoptive T-Cell transfer
In addition, two- panel discussions on both days will bring some key
questions to light including the commercial vial ability of personalised
treatments.
However, it has also become clear that cancer cells have
different ways of eluding the immune system, which makes creating
effective vaccines difficult.
Researchers are also studying the best way to give vaccines, looking
to see if they work better when used alone or with other types of cancer
treatments. Therefore key discussion points in our 2-day interactive
panel will include:
- Development of combination treatments - which ones are best?
- Driving the next generation tools in cancer immunotherapy
- How will technology and data systems need to change in order to allow personalised treatment to evolve?
